AVNS

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.

Wall Street analysts forecast AVNS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVNS is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Avanos Medical Inc revenue for the last quarter amounts to 177.80M USD, increased 4.34 % YoY.

Avanos Medical Inc. EPS for the last quarter amounts to -0.03 USD, decreased -133.33 % YoY.

Avanos Medical Inc (AVNS) has 2227 emplpoyees as of December 15 2025.

Today AVNS has the market capitalization of 545.42M USD.